Navigation Links
Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO
Date:6/1/2008

eline includes investigational compounds in phase 2 and phase 1 clinical development. Exelixis has established strategic corporate alliances with major pharmaceutical and biotechnology companies, including GlaxoSmithKline, Bristol-Myers Squibb, Genentech, Wyeth Pharmaceuticals, and Daiichi-Sankyo. For more information, please visit the company's web site at http://www.exelixis.com .

Forward-Looking Statements

This press release contains forward-looking statements, including without limitation statements related to the future development and potential efficacy of XL184 and the timing of the initiation of pivotal trials for XL184. Words such as "hope," "plan," "continue," "will," "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon our current plans, assumptions, beliefs and expectations. Forward-looking statements involve risks and uncertainties. Our actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the potential failure of XL184 to demonstrate safety and efficacy in clinical testing, our ability to initiate and complete pivotal trials for XL184 at the referenced times; the timing and level of expenses associated with the growth of proprietary programs and other collaborations; the therapeutic and commercial value of XL184 and our other compounds; our relationship with our partners; and our ability to enter into new collaborations, continue existing collaborations and receive milestones and royalties under our collaborative agreements. These and other risk factors are discussed under "Risk Factors" and elsewhere in our quarterly report on Form 10-Q for the quarter ended March 28, 2008, and other filings with the Securities and Exchange Commission. We exp
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GlaxoSmithKline Accelerates Review of Exelixis XL880
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
6. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
7. Phase 2 Trial Results for Exelixis XL784 Presented at the 2007 American Society of Nephrology Conference
8. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
9. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
10. Exelixis Announces First Quarter 2008 Financial Results
11. Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Middle Eastern MRI systems market is fast growing. MRI being ... of medicine like cardiology, neurology and orthopedics. It is replacing ... is as safer tool as it does not use ionizing ... into Open system, closed system and straight or upright system. ... it is preferred over that currently common closed type as ...
(Date:6/1/2015)... June 1, 2015  Diomics, an innovator in DNA ... , global financial executive, has joined Diomics, board of ... than 25 years of industry experience in broad global ... a managing director at Credit Suisse and JP Morgan, ... Witter. "Diomics is on the forefront of ...
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global Power Wheelchair Industry Report 2014" ... Global Power Wheelchair Industry Report 2014 is a ... of the power wheelchair industry. The ... including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3Richard M. Weissman joins Diomics Board of Directors 2Global Power Wheelchair Industry Trends 2015-2020 2
... Oct. 7 Sunridge International (OTC Bulletin Board: ... Trabeculoplasty (PNT) non-invasive treatment for glaucoma and ocular hypertension, ... by Beijing Vision World Trading Co. Ltd. (BVW), in ... patient research studies before gaining regulatory approval by China,s ...
... Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ... evaluating the use of Nexavar® (sorafenib) tablets will be presented ... October 8-12, 2010 in Milan, Italy. "It,s ... its first indication, advanced kidney cancer, and since that time ...
Cached Medicine Technology:Sunridge Advances its PNT Glaucoma Treatment Throughout China 2Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 2Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 3Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress 4
(Date:6/1/2015)... 2015 Sharenote, a leading web-base electronic ... Healthcare Industry this week in Louisiana. The entrepreneurial trio ... days to provide potential providers with the tools and ... monitor risk within their network. , Find out ... being used by more than 250 practices. , ...
(Date:6/1/2015)... Orlando, Florida (PRWEB) June 01, 2015 ... have generously donated $88,000 of the best superfood ... of the record-breaking floods in Texas. , "Monica ... Adams and Natural News in distributing Living Fuel Super ... victims of the millennial floods in Texas," KC Craichy ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 More than 22 ... summer months when school is out and they lose access ... Month and America’s dairy farmers and milk companies are on ... need with The Great American Milk Drive. , In ... provided in the school cafeteria for the bulk of their ...
(Date:6/1/2015)... Northridge dentist , Dr. Michel Elyson, ... promotion on Invisalign for a limited time only. With ... to $3,700. Patients can find out about their candidacy ... the extent of correction they need. This promotion expires ... any other offer. , Invisalign has continued to ...
(Date:6/1/2015)... 01, 2015 Listen to Volvo’s Director ... companies are using more granular data to create better ... new industry voices in Josep Celaya Gonzalez, CIO at ... ParkTAG. As an automotive insurer, MAPFRE are well versed ... easy-to-use solution to the driver. Award winning start-up ParkTAG ...
Breaking Medicine News(10 mins):Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:Summer Nutrition Vital for Kids who Depend on Schools for Healthy Foods 2Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2
... in a New Law and Manages Applicants, PaperworkMADRID, April 1 ... IBM ), today announced that Junta de Castilla ... in Spain, will be helping its citizens gain quicker access to ... a new system built around IBM ILOG JRules. The new system ...
... 2009) It appears that a drug commonly used ... on the compulsive behavior of kleptomaniacs it curbs their ... of Minnesota., The Medical School,s Department of Psychiatry conducted an ... who spent an average of at least one hour a ...
... Uneasiness and Limited Resources Create Missed Opportunities for Smokers ... (HCPs) are one of the most important allies a ... health risks of smoking and learning about the quitting ... smokers (21%) never talked to a HCP ...
... first-ever genetic link to the reason African-Americans are at increased ... researchers at the University of Alabama at Birmingham (UAB) is ... testing. In the study, African-Americans with a Pro72 protein variant ... advanced form of colon cancer compared to whites, the researchers ...
... HARBIN, China, March 31 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a,leading fully ... Republic of China ("PRC"), today announced that it ... Exchange Commission,for its Annual Report on Form 10-K. ...
... providing patients with safe, reliable care using affordable medical equipment from ... ... with an unrelenting economic outlook, many surgery centers and hospitals are ... from DRE, a medical and surgical equipment supplier recently named ...
Cached Medicine News:Health News:Spain's Junta De Castilla y Leon Streamlines Benefits Delivery for Dependent Care With IBM ILOG JRules 2Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 2Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 3Health News:Not Enough Smokers Find Quit Support at the Doctor's Office 4Health News:China Sky One Medical, Inc. Files for Extension to File Form 10-K 2Health News:Healthcare Facilities Focusing on Affordability, Dependability 2Health News:Healthcare Facilities Focusing on Affordability, Dependability 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
ESR-Vacuum Tubes are evacuated tubes used for the collection of venous blood. ESR-Vacuum Tubes are used to transport and process blood for testing the Erythrocyte Sedimentation Rate (ESR) of whole bl...
Medicine Products: